US Stock MarketDetailed Quotes
BCYC Bicycle Therapeutics
- 20.400
- +0.050+0.25%
Close Nov 29 13:00 ET
- 20.300
- -0.100-0.49%
Post 17:01 ET
1.41BMarket Cap-6219P/E (TTM)
20.720High20.200Low208.92KVolume20.360Open20.350Pre Close4.26MTurnover0.47%Turnover RatioLossP/E (Static)69.05MShares28.67052wk High1.69P/B898.49MFloat Cap14.33052wk Low--Dividend TTM44.04MShs Float62.075Historical High--Div YieldTTM2.56%Amplitude6.240Historical Low20.399Avg Price1Lot Size
About Bicycle Therapeutics Company
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Company Profile
SymbolBCYC
Company NameBicycle Therapeutics
Listing DateMay 23, 2019
Issue Price14.00
Founded2009
CEODr. Kevin Lee, M.B.A.
MarketNASDAQ
Employees284
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressGranta Park Great Abington,Portway Building,Blocks A & B
CityCambridge
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCB21 6GS
Phone44-1223-261503
Company Executives
- Name
- Position
- Salary
- Dr. Kevin Lee, M.B.A.
- Director and Chief Executive Officer
- 5.54M
- Alethia Young
- Chief Financial Officer
- 2.88M
- Nigel Crockett
- Chief Business Officer
- --
- Alistair Milnes
- Chief Operating Officer
- --
- Dr. Michael Charles Ferguson Hannay, D.Sc.
- Chief Product and Supply Chain Officer
- --
- Travis Thompson
- Chief Accounting Officer
- --
- Dr. Santiago Arroyo
- Chief Development Officer
- 2.68M
- Dr. Nicholas Keen, PhD
- Chief Scientific Officer
- --
- Dr. Michael Skynner, PhD
- Chief Technology Officer
- --
- Pierre Legault, C.P.A.,M.B.A.
- Chairman of the Board
- 1.06M
- Dr. Jose-Carlos Gutierrez-Ramos, PhD
- Independent Director
- 482.29K
- Sir Greg Winter, F.R.S.
- Independent Director
- 477.04K
- Dr. Felix J. Baker,PhD
- Independent Director
- --
- Stephen Sands
- Independent Director
- --
- Richard N. Kender, M.B.A.
- Independent Director
- 526.91K
- Janice Bourque, M.B.A.
- Independent Director
- 495.41K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data